4:21 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Rani Therapeutics Holdings Nasdaq/NYSE Compliance Notice
Rani Therapeutics received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement. As part of this process, the company's listing was transferred from the Nasdaq Global Market to the Nasdaq Capital Market effective November 12, 2026. The company now has until May 10, 2027, to meet the requirement, which may involve a reverse stock split if necessary.
- Counterparty
- Nasdaq
- Term
- 180 days